Orchid Ventures, Inc.: Orchid Ventures Announces Partnership with Eurox Pharma GmbH on Submission to German Authorities for Medical Device Approval

VANCOUVER, BC / ACCESSWIRE / January 11, 2022 / Orchid Ventures, Inc. (the "Company" or "Orchid") (CSE:ORCD) (OTC PINK:ORVRF), a multi-state cannabis innovation company, today announced it has entered

Related Keywords

Germany ,Portugal ,California ,United States ,Canada ,United Kingdom ,Brazil ,Vancouver ,British Columbia ,Canadian ,German ,Corey Mangold ,Bernhard Babel ,Eurox Pharma Gmb ,Company Or Orchid ,European Union ,Company Canadian ,Orchid Ventures Inc ,Orchid Ventures ,Eurox Pharma Gmbh ,Medical Device ,Medical Device Approval ,Eurox Pharma ,Intellectual Property ,Purtec Delivery Systems ,Securities Litigation Reform Act ,Orchid Essentials ,Orchid ,Dentures ,Nnounces ,Partnership ,Aurox ,Dharma ,Mbh ,Submission ,Authorities ,Medical ,Device ,Approval ,